XML 45 R34.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation (Tables)

3 Months Ended

Jun. 30, 2023

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Schedule Of Assumptions Used In Monte Carlo Simulation Model

The assumptions used in the Monte-Carlo simulation model to value our market-based restricted stock units were as follows:


			Three Months Ended June 30,
			2023						2022
Risk-free interest rate			4.4		%				3.3		%
Expected volatility			25 - 59%						33 - 56%
Weighted-average volatility			39		%				43		%
Expected dividends			None						None

Schedule of Repurchase Agreements

The following table summarizes total shares repurchased during the three months ended June 30, 2023 and 2022:


			November 2020 Program												August 2022 Program												Total
(In millions)			Shares						Amount						Shares						Amount(a)						Shares						Amount
Three months ended June 30, 2023			—						$	—					2.6						$	325					2.6						$	325

Three months ended June 30, 2022			2.5						$	320					—						$	—					2.5						$	320
(a)Amount excludes excise taxes. Accrued excise taxes are included in accrued and other current liabilities and additional paid-in capital on the Condensed Consolidated Balance Sheets.

Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award

The following table summarizes our stock option activity for the three months ended June 30, 2023:


						Options (in thousands)						Weighted- Average Exercise Prices						Weighted- Average Remaining Contractual Term (in years)						Aggregate Intrinsic Value (in millions)
Outstanding as of March 31, 2023						121						$	40.43

Granted						1						127.42
Exercised						(2)						90.77

Outstanding as of June 30, 2023						120						$	40.21					1.63						$	11
Vested and expected to vest						120						$	40.21					1.63						$	11
Exercisable as of June 30, 2023						120						$	40.21					1.63						$	11

The following table summarizes our restricted stock units activity for the three months ended June 30, 2023:


			Restricted Stock Units (in thousands)						Weighted- Average Grant Date Fair Values
Outstanding as of March 31, 2023			7,502						$	128.54

Granted			3,838						128.56
Vested			(2,150)						130.19
Forfeited or cancelled			(269)						129.97
Outstanding as of June 30, 2023			8,921						$	128.11

The following table summarizes our performance-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the three months ended June 30, 2023:


			Performance- Based Restricted Stock Units (in thousands)						Weighted- Average Grant Date Fair Value
Outstanding as of March 31, 2023			557						$	130.03
Granted			682						128.66
Vested			(73)						127.98
Forfeited or cancelled			(242)						128.77
Outstanding as of June 30, 2023			924						$	129.51

The following table summarizes our market-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the three months ended June 30, 2023:


			Market-Based Restricted Stock Units (in thousands)						Weighted- Average Grant Date Fair Value
Outstanding as of March 31, 2023			822						$	149.98
Granted			143						152.92
Vested			(17)						145.78
Forfeited or cancelled			(445)						148.09
Outstanding as of June 30, 2023			503						$	152.63

The following table summarizes stock-based compensation expense resulting from stock options, restricted stock units, market-based restricted stock units, performance-based restricted stock units, and the ESPP purchase rights included in our Condensed Consolidated Statements of Operations (in millions):


			Three Months Ended June 30,
			2023						2022
Cost of revenue			$	2					$	2
Research and development			93						81
Marketing and sales			11						13
General and administrative			24						29
Stock-based compensation expense			$	130					$	125